Results 111 to 120 of about 5,151 (200)

Chronic Kidney Disease – Where Next? : Predicting Outcomes And Planning Care Pathways [PDF]

, 2014
Peer reviewedPublisher ...
Black, Corri, Fluck, Nicholas, Marks, Angharad   +2 more
core   +1 more source

Endothelális diszfunkció és oxidatív stressz szerepe a juvenilis esszenciális hypertóniában és obezitásban. = The role of endothelium dysfunction and oxidative stress in juvenile essential hypertony and obesity. [PDF]

, 2012
OTKA kutatásunkban a következő főbb témákban: „Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension”, „Eritropoezisstimuláló hatóanyagok és az oxidatív stressz ...
Baráth, Ákos, Bereczki, Csaba, Börcsökné dr. Endreffy, Emőke, Haszon, Ibolya, Maróti, Zoltán, Monostori, Péter, Túri, Sándor, Vécseiné dr. Karg, Eszter, Wittmann, Gyula   +8 more
core  

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study. [PDF]

Nephrol Dial Transplant, 2021
Nangaku M, Kondo K, Ueta K, Kokado Y, Kaneko G, Matsuda H, Kawaguchi Y, Komatsu Y.   +7 more
europepmc   +1 more source

Innovation and market dynamics in the EPO market [PDF]

In this paper we study the demand and supply of erythropoietin in four Nordic countries, using an econometric model based on discrete choice and a random utility model.
Sorisio, Enrico, Strøm, Steinar
core  

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials.

Am J Nephrol, 2022
Agarwal R, Anand S, Eckardt KU, Luo W, Parfrey PS, Sarnak MJ, Solinsky CM, Vargo DL, Winkelmayer WC, Chertow GM.   +9 more
europepmc   +1 more source

Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective

Nursing: Research and Reviews, 2013
Loraine Derbyshire, Colin W Thain School of Health, University of Central Lancashire, Preston, United Kingdom Abstract: Chemotherapy induced anemia (CIA) is a frequent complication of anticancer treatment, but often remains untreated. The main presenting
Derbyshire L, Thain CW
doaj  

The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study. [PDF]

Indian J Hematol Blood Transfus, 2022
Ak MA, Sahip B, Geduk A, Ucar MA, Kale H, Hacibekiroglu T, Polat MG, Kalpakci Y, Bolaman AZ, Guvenc B, Ertop S.   +10 more
europepmc   +1 more source

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.

Am J Nephrol, 2021
Akizawa T, Tanaka-Amino K, Otsuka T, Yamaguchi Y.   +3 more
europepmc   +1 more source

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study

Cancer Management and Research, 2016
Jean-Loup Mouysset,1 Beata Freier,2 Joan van den Bosch,3 Charles Briac Levaché,4 Alain Bols,5 Hans Werner Tessen,6 Laura Belton,7 G Chet Bohac,8 Jan-Henrik Terwey,9 Giuseppe Tonini101Department of Medical Oncology, Clinique Rambot Provencale, Aix ...
Mouysset JL, Freier B, van den Bosch J, Levaché CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G   +9 more
doaj  

Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan. [PDF]

Clin Exp Nephrol, 2021
Hayashi T, Kato H, Tanabe K, Nangaku M, Hirakata H, Wada T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.   +19 more
europepmc   +1 more source